Skip to main content
Back
Watch Compare

Rallybio Corp

Data quality: 100%
RLYB
Nasdaq Manufacturing Chemicals
$8.12
▼ $0.10 (-1.22%)
Mkt Cap: 42.95 M
Price
$8.12
Mkt Cap
42.95 M
Day Range
$8.08 — $8.28
52-Week Range
$1.79 — $11.49
Volume
30,155
Open $8.16
50D / 200D Avg
$7.29
11.31% above
50D / 200D Avg
$5.31
52.93% above

Quick Summary

Key Takeaways

Negative free cash flow of -29.81 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)43.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-16.47%
Above sector avg (-53.47%)
ROIC-47.88%
Net Margin-1046.39%
Op. Margin-3853.61%

Safety

Debt / Equity
N/A
Current Ratio14.74
Interest CoverageN/A

Valuation

PE (TTM)
-4.78
Below sector avg (-1.47)
P/B Ratio0.68
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -4.8 -1.5
P/B 0.7 1.6
ROE % -16.5 -53.5
Net Margin % -1046.4 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

BRSIX BRSIX
0.06% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 43.00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 858,000.0 Net Income (TTM) -8.98 M
ROE -16.47% ROA -15.13%
Gross Margin N/A Operating Margin -3853.61%
Net Margin -1046.39% Free Cash Flow (TTM) -29.81 M
ROIC -47.88% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 14.74
Interest Coverage N/A Asset Turnover 0.01
Working Capital 62.11 M Tangible Book Value 63.03 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4.78 Forward P/E N/A
P/B Ratio 0.68 P/S Ratio 50.06
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -69.41%
Market Cap 42.95 M Enterprise Value 10.83 M
Per Share
EPS (Diluted TTM) -1.59 Revenue / Share 0.16
FCF / Share -5.64 OCF / Share -5.64
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 332.07%
SBC-Adj. FCF -36.38 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 858,000.0 600,000.0 — — —
Net Income -8.98 M -57.78 M -74.56 M -66.65 M -47.01 M
EPS (Diluted) -1.59 -1.33 -1.84 -2.09 —
Gross Profit — — — — —
Operating Income -33.06 M -60.50 M -78.93 M -67.88 M -45.65 M
EBITDA — — — — —
R&D Expenses 19.60 M 41.51 M 53.54 M 40.69 M 26.91 M
SG&A Expenses — — — — —
D&A 92,000.0 131,000.0 150,000.0 167,000.0 109,000.0
Interest Expense — — — 0.0 10,000.0
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 62.26 M 68.11 M 115.62 M 180.44 M 182.19 M
Total Liabilities 4.31 M 6.45 M 9.44 M 11.12 M 6.58 M
Shareholders' Equity 57.96 M 61.65 M 106.18 M 169.32 M 175.60 M
Total Debt — — — — —
Cash & Equivalents 31.37 M 13.90 M 24.49 M 56.96 M 175.33 M
Current Assets 61.25 M 67.84 M 114.79 M 179.50 M 180.87 M
Current Liabilities 4.22 M 6.24 M 9.26 M 10.74 M 6.55 M